Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Depreciation and Depletion (2020 - 2025)

Zai Lab (ZLAB) has disclosed Depreciation and Depletion for 6 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 20.0% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, up 7.06% year-over-year, with the annual reading at $9.1 million for FY2025, 5.81% up from the prior year.
  • Depreciation and Depletion hit $2.4 million in Q4 2025 for Zai Lab, roughly flat from $2.4 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $2.5 million in Q1 2023 to a low of $1.3 million in Q1 2021.
  • Historically, Depreciation and Depletion has averaged $2.0 million across 5 years, with a median of $2.0 million in 2022.
  • Biggest five-year swings in Depreciation and Depletion: soared 44.63% in 2021 and later fell 14.29% in 2023.
  • Year by year, Depreciation and Depletion stood at $1.7 million in 2021, then increased by 17.65% to $2.0 million in 2022, then grew by 15.0% to $2.3 million in 2023, then dropped by 13.04% to $2.0 million in 2024, then rose by 20.0% to $2.4 million in 2025.
  • Business Quant data shows Depreciation and Depletion for ZLAB at $2.4 million in Q4 2025, $2.4 million in Q3 2025, and $2.3 million in Q2 2025.